Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28.
作者： Hironobu Minami , Kimie Sai , Mayumi Saeki , Yoshiro Saito , Shogo Ozawa
DOI: 10.1097/FPC.0B013E328014341F
关键词:
摘要: … For association analysis, diplotypes of UGT1A gene segments [(1A1, 1A7, 1A9, 1A10), and Block C (common exons 2–5)] and combinatorial haplotypes (1A9-1A7-1A1) were used. The …
lww.com
sci-hub.se 参考文章(31)
Jeffrey G Supko, Rocio Garcia-Carbonero, Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins Clinical Cancer Research. ,vol. 8, pp. 641- 661 ,(2002)
A Gouyette, G G Chabot, M de Forni, A Mathieu-Boué, J M Extra, R Bugat, M E Marty, I Madelaine, S Culine, Phase I and Pharmacokinetic Study of the Camptothecin Derivative Irinotecan, Administered on a Weekly Schedule in Cancer Patients Cancer Research. ,vol. 54, pp. 4347- 4354 ,(1994)
Mark J. Ratain, Everett E. Vokes, Timothy M. Lestingi, Jacqueline Ramirez, Rosemarie Mick, Elora Gupta, Metabolic Fate of Irinotecan in Humans: Correlation of Glucuronidation with Diarrhea Cancer Research. ,vol. 54, pp. 3723- 3725 ,(1994)
M Saeki, Y Saito, H Jinno, K Sai, S Ozawa, K Kurose, N Kaniwa, K Komamura, T Kotake, H Morishita, S Kamakura, M Kitakaze, H Tomoike, K Shirao, T Tamura, N Yamamoto, H Kunitoh, T Hamaguchi, T Yoshida, K Kubota, A Ohtsu, M Muto, H Minami, N Saijo, N Kamatani, J-i Sawada, Haplotype structures of the UGT1A gene complex in a Japanese population. Pharmacogenomics Journal. ,vol. 6, pp. 63- 75 ,(2006) , 10.1038/SJ.TPJ.6500335
Maki Ando, Yuichi Ando, Yoshitaka Sekido, Masahiko Ando, Kaoru Shimokata, Yoshinori Hasegawa, Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients. Japanese Journal of Cancer Research. ,vol. 93, pp. 591- 597 ,(2002) , 10.1111/J.1349-7006.2002.TB01295.X
Christoph Köhle, Bernd Möhrle, Peter A. Münzel, Matthias Schwab, Dorothee Wernet, Osama A. Badary, Karl Walter Bock, Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochemical Pharmacology. ,vol. 65, pp. 1521- 1527 ,(2003) , 10.1016/S0006-2952(03)00074-1
Chiyoe Kitagawa, Maki Ando, Yuichi Ando, Yoshitaka Sekido, Kenji Wakai, Kazuyoshi Imaizumi, Kaoru Shimokata, Yoshinori Hasegawa, Genetic polymorphism in the phenobarbital-responsive enhancer module of the UDP-glucuronosyltransferase 1A1 gene and irinotecan toxicity. Pharmacogenetics and Genomics. ,vol. 15, pp. 35- 41 ,(2005) , 10.1097/01213011-200501000-00006
Federico Innocenti, Wanqing Liu, Peixian Chen, Apurva A. Desai, Soma Das, Mark J. Ratain, Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. Pharmacogenetics and Genomics. ,vol. 15, pp. 295- 301 ,(2005) , 10.1097/01213011-200505000-00004
Ji-Youn Han, Hyeong-Seok Lim, Eun Soon Shin, Yeon-Kyeong Yoo, Yong Hoon Park, Jong-Eun Lee, In-Jin Jang, Dae Ho Lee, Jin Soo Lee, Comprehensive Analysis of UGT1A Polymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non–Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin Journal of Clinical Oncology. ,vol. 24, pp. 2237- 2244 ,(2006) , 10.1200/JCO.2005.03.0239
L Iyer, C D King, P F Whitington, M D Green, S K Roy, T R Tephly, B L Coffman, M J Ratain, Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. Journal of Clinical Investigation. ,vol. 101, pp. 847- 854 ,(1998) , 10.1172/JCI915